Entries by aaron

Nirsevimab found Effective in Preventing RSV-Associated Hospitalizations Among Infants in new research

In a significant development in pediatric healthcare, nirsevimab, a long-acting monoclonal antibody, has demonstrated robust real-world effectiveness in protecting infants against respiratory syncytial virus (RSV)-associated hospitalizations, according to an analysis by the New Vaccine Surveillance Network during the period of October 1, 2023, to February 29, 2024. The report was published in CDC Morbidity and […]

MRI-Guided Focal Therapy Shows Promising 2-Year Outcomes for Intermediate-Risk Prostate Cancer: Study

Prostate cancer is a common malignancy affecting men worldwide, and intermediate-risk prostate cancer (PCa) presents a challenging treatment scenario. MRI-guided focal therapy (FT) has emerged as a promising approach, allowing for targeted treatment while preserving healthy prostate tissue. However, long-term outcomes of this technique remain underexplored. A recent study aimed to evaluate the 2-year oncological […]

How Effective isSingle Lung Ventilation with Double endotracheal tubes?

Recently published research paper discusses the effectiveness of single lung ventilation (SLV) using a double lumen tube (DLT) for providing surgical exposure in the thoracic cavity. It emphasizes the protective benefits of SLV for a healthy lung, highlighting the types of unhealthy lung fluids it protects from, such as blood, lavage fluid, malignant, or purulent […]

Once-weekly administration of apraglutide reduces dependency on parenteral support in short bowel syndrome: Phase 3 trial

USA: Findings from phase 3 STARS trial demonstrate the potential for apraglutide to improve the standard of care for all adult patients with short bowel syndrome with intestinal failure (SBS-IF) dependent on parenteral support as the only GLP-2 with once-weekly administration, if approved.  The study showed that treatment with apraglutide was associated with a reduction […]

FDA approves semaglutide for major heart disease prevention among obese

The US Food and Drug Administration (FDA) has approved semaglutide (Wegovy) for reducing risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight. Wegovy should be used in addition to a reduced calorie diet and increased physical activity. Cardiovascular disease is a group of diseases of the […]

Higher intake of nuts in early pregnancy enhances neuropsychological development and reduces peer problems in children: Study

It is already known that Maternal diet during pregnancy is associated with child development. Nuts are nutrient-dense foods and provide fatty acids, vitamins, fibre, minerals and proteins. Pregnant women who consume nuts may potentially reduce the likelihood of their 5-year-old children experiencing peer problems, according to a study published in the Journal of Pediatric Gastroenterology […]

Full-mouth rehabilitation with dental implants viable option for patients with cognitive and physical disabilities: Study

UK: A 14-year cohort study published in the Journal of Prosthetic Dentistry has found implant-supported prostheses to be effective and that oral rehabilitation under the specified conditions is stable. The researchers suggest that clinicians should consider this full-mouth rehabilitation with dental implants under general anesthesia (GA) as a viable option for cognitively and physically disabled […]

Mazdutide Shows Promise in Controlling blood sugar and Obesity in Diabetes Patients: Study

Mazdutide, a dual agonist drug was found to target weight reduction and additionally to manage blood glucose levels in individuals with overweight and obesity. The key highlights of this study was published in the recent edition of Frontiers in Endocrinology. Amidst the anticipation surrounding the efficacy of Mazdutide, the concerns regarding the scarcity of comprehensive evidence […]

KDIGO 2024 Guideline for ANCA Vasculitis management aims to improve care

USA: An article published in Kidney International reports a new guideline from Kidney Disease: Improving Global Outcomes (KDIGO) that provides updated recommendations on the management of antineutrophilic cytoplasmic antibody (ANCA)–-associated vasculitis (AAV). The updated guideline addresses key recent developments, the recent regulatory approval of the C5a receptor inhibitor avacopan as an add-on therapy to the […]